Research Interests
    Our laboratory is involved in studies concerning the role of a newly discovered human herpesvirus, HHV-8, in development and pathogenesis of Kaposi's sarcoma. Kaposi's sarcoma-associated herpesvirus (KSHV) or HHV-8, is a newly discovered member of the human herpesvirus family whose DNA sequences have been found in samples of Kaposi's sarcoma (KS). The discovery of a new human herpesvirus has generated a great deal of interest which is magnified by it's potential role in the establishment of human cancers. KSHV DNA sequences have been detected in tissues from AIDS-associated, classic and endemic forms of KS as well as in some EBV-infected lymphomas and non-KS skin cancers.

    Our studies are involved in 1) determining the prevalence of Kaposi's sarcoma-associated herpesvirus (KSHV) antibodies in different, well characterized populations under varying levels of risk for development of Kaposi's sarcoma (KS), 2) in collaboration with Dr. Charles Rinaldo, identifying viral epitopes targeted by CD8+ cytolytic T-cells, 3) investigating the interactions of HHV-8 with other lymphotrophic herpesviruses during acute infections and viral reactivation events and 3) investigating paracrine effects of different viral proteins on carcinogensis.

 
Selected Publications
  1. Montgomery JD, Hensler HR, Jacobson LP, Jenkins FJ. Validation of a low cost computer-based method for quantification of immunohistochemistry-stained sections. Appl Immunohistochem Mol Morphol. 2008 Jul;16(4):400-4.
  2. Nawar EW, Cole SR, Farzadegan H, Witt MD, Jenkins FJ, Margolick JB, Phair JP, Jacobson LP. Sexual activity and Kaposi's sarcoma among human immunodeficiency virus type 1 and human herpesvirus type 8-coinfected men. Ann Epidemiol. 2008 Jul;18(7):517-21. Epub 2008 May 27.
  3. Rappocciolo G, Hensler HH, Jais M, Reinhart TA, Pegu A, Jenkins FJ, Rinaldo CR. HHV-8 infects and replicates in primary cultures of activated B lymphocytes through DC-sign. J Virol. 2008 Mar 12.
  4. Sutcliffe S, Giovannucci E, Gaydos CA, Viscidi RP, Jenkins FJ, Zenilman JM, Jacobson LP, De Marzo AM, Willett WC, Platz EA. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1573-80.
  5. Jenkins FJ, Hayes RB, Jackson A, Pizza G, Mbisa G, Whitby D, Goedert JJ. Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis. 2007 Jul 15;196(2):208-11.

    Complete Publication Listing
 
 
Other Links
http://www.idm.pitt.edu/faculty/jenkins.html
University of Pittsburgh
 
   
     
  Frank J Jenkins , Ph.D., Associate Professor
Office:  Hillman Cancer Center, Research Pavilion, G.17b
Lab:Hillman Cancer Center, Research Pavilion G.16
Phone:412-623-3233
Fax: 412-623-1119
fjenkins@pitt.edu
 
Academic Affiliations
  • Department of Pathology
    University of Pittsburgh
    School of Medicine
    Primary Appointment

  • Department of Infectious Diseases and Microbiology (School of Public Health)
    Secondary Appointment

  • Center for Neuroscience
    University of Pittsburgh Cancer Institute

 
Education
  • 1978 B.A. Biology
    North Texas State University
    Denton, TX

  • 1979 M.S. Biology
    North Texas State University
    Denton, TX

  • 1984 Ph.D. Medical Microbiology
    Pennsylvania State University
    Hershey, PA

  • 1984 - 1987 Postdoctoral Fellow (Virology)
    University of Chicago
    Chicago, IL

 
Lab Personnel

Heather Hensler, Jill Montgomery, Patrick Shea, Stefanie Morosky, Jim Ackerman, Danica Cowan